Skip to main content

Table 4 Multiple regression analysis for predictors of 30-day mortality in group 1

From: Mean platelet volume to platelet count ratio as a laboratory indicator of mortality in pneumonia following ischemic stroke

Predictors of 30-day mortality

Group 1

95% confidence intervals

p value

Age > 65 years

Non-survivors

12 (54%)

0.833–0.987

0.03*

Survivors

12 (46%)

Sex (males/females)

Non-survivors

19 (51%)/18(49%)

0.63–1.34

0.34

Survivors

8 (52%)/6(48%)

Smoking

Non-survivors

12 (60%)

0. 13–1.25

0.25

Survivors

8 (40%)

Mechanical ventilation

Non-survivors

8 (33%)

0.35–0.26

0.01*

Survivors

6 (22%)

GCS at pneumonia occurrence < 9

Non-survivors

15 (63%)

11.12–21.30

0.001*

Survivors

10 (37%)

Pleural effusion in CXR

Non-survivors

11 (46%)

0.47–1.38

0.99

Survivors

12 (44%)

Pulmonary infiltrates in CXR

Non-survivors

11 (46%)

0.36–1.14

0.224

Survivors

12 (44%)

PSI risk class ≥ 4

Non-survivors

15 (63%)

1.095–2.364

0.04*

Survivors

6 (22%)

CURB-65 scores ≥ 3

Non-survivors

18 (75%)

1.23–2.99

0.01*

Survivors

14 (52%)

Increased MPV/PC ratio

Non-survivors

16 (67%)

2.9–2.23

0.03*

Survivors

8 (30%)

  1. GCS Glasgow Coma Scale, NIHSS National Institutes of Health Stroke Scale, CXR chest radiograph, PSI pneumonia severity index, MPV/pc ratio mean platelet volume/platelet count ratio
  2. *Significant